Latest Headlines

  1. Hologic Launches New Scalable Options For Panther System In The United States And Europe 2/5/2020

    New product offerings within the Panther Scalable Solutions (PSS) portfolio are now commercially available in the United States and Europe, Hologic (Nasdaq: HOLX) announced today

  2. Accumen’s 3DR Labs Partners With Resonance Health To Expand Its MRI Analysis Services 2/5/2020

    Accumen Inc., the leader in healthcare performance, announced today that its 3DR Labs, LLC company is partnering with Resonance Health Limited (ASX: RHT) to provide FerriSmart magnetic resonance imaging- (MRI-) based liver iron concentration reports for its clients

  3. Lab Researchers Develop 3D ‘Brain-On-A-Chip’ Device Capable Of Long-Term Recording Of Neural Activity 2/5/2020

    Lawrence Livermore National Laboratory (LLNL) engineers and biologists have developed a “brain-on-a-chip” device capable of recording the neural activity of living brain cell cultures in three dimensions, a significant advancement in the realistic modeling of the human brain outside of the body

  4. Predictive Oncology Launches Innovative Specialty Media For Growing Ovarian Tumors In The Lab 2/5/2020

    TumorGenesis, Inc. a subsidiary of Predictive Oncology, Inc. (NASDAQ: POAI) has selected US Biological Corporation of Salem, Massachusetts as the manufacturer and distributor of its innovative culture media for growing ovarian tumor cells

  5. Porvair Sciences Launch Phospholipid Removal Plate 2/4/2020

    Porvair Sciences announce Microluteä PLR - a new benchmark product for phospholipid removal. The 96-well microplate provides effective removal (>99%) of phospholipids and proteins with higher levels of reproducibility from plasma and serum samples while maintaining maximum recovery of target analytes

  6. CDI Labs Launches Two New Powerful Assays To Its Biomarker Discovery Platform 2/4/2020

    CDI Laboratories, Inc. Antygen Division announced the addition of two powerful new assays to its biomarker discovery platform

  7. Helix Selects Swift Biosciences To Power Exome+™ Assay With Swift 2S™ Turbo DNA Library System 2/4/2020

    Swift Biosciences, Inc ("Swift") and Helix OpCo, LLC ("Helix") today announced a Partnership Agreement to leverage Swift's 2S™ Turbo DNA library preparation for Helix's Exome+™ assay. Helix, a population genomics company, uses the Exome+™ assay to power population health programs focused on accelerating the integration of genomics into clinical care and facilitating novel genetic discovery

  8. Drawbridge Health Announces CE Mark For The OneDraw™ A1C Test System 2/4/2020

    Drawbridge Health today announced that it has completed the CE Mark process for the OneDraw™ A1C Test System – a novel, easy to use device that enables blood to be drawn comfortably and conveniently by a healthcare professional (HCP)

  9. FDA Takes Significant Step In Coronavirus Response Efforts, Issues Emergency Use Authorization For The First 2019 Novel Coronavirus Diagnostic 2/4/2020

    Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) to enable emergency use of the Centers for Disease Control and Prevention's (CDC) 2019-nCoV Real-Time RT-PCR Diagnostic Panel

  10. Siemens Healthineers Wins Bid To Become Primary Supplier For Quest Diagnostics Immunoassay Testing With Atellica Solution 2/3/2020

    Siemens Healthineers (SHL.DE) announced today that it was selected by Quest Diagnostics, the world's leading provider of diagnostic information services, to be its preferred supplier for immunoassay testing